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Abstract  
Osteoporosis is a common disease in old ages, trace minerals are 
central components of bone density and hardness. The present study aims to 
measure copper, magnesium, iron, calcium and phosphorus levels in 
osteoporotic southern Gaza patients and control groups. A case –control study 
included 35 osteoporotic patients and 35 controls aged 40-70 years. Copper, 
magnesium iron, calcium and phosphorus levels were measured in the serum 
at Palestinian Medical Relieve Society-Gaza by absorption spectrophotometry 
method-XLFS Kit (Diasys Diagnostic System GmbH). Serum copper and 
magnesium levels in osteoporotic patients (74.3±9.8μg/dL 1.56±0.18mg/dl) 
respectively is significantly (p<0.001) lower  than control     (98.3±15.2μg/dL, 
2.06±0.13mg/dl ). The present work indicated a positive correlation between 
copper and magnesium levels (r=0.627, p<0.00), positive correlation between 
copper and number of daily meals  (r=0.263, p<0.030), and also positive 
correlation between calcium and daily exercises (r=0.449, p<0.010). In 
conclusion copper and magnesium levels are significantly lower in 
postmenopausal women and men with osteoporosis. Optimizing levels of 
those trace minerals in old people is beneficial in prevention of osteoporosis. 
Daily exercises and ingestion of food containing trace minerals is highly 
recommended for this age group. 
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Introduction  
Osteoporosis is a systemic skeletal disease characterized by low bone 
mass and minerals deterioration of bone tissue, with a consequent  increase in 
bone fragility and susceptibility to fractures, all individuals if they live long 
enough will develop osteoporosis; some due to various illnesses or as part of 
hormonal deficiency. It occurs as because of unbalance between bone 
formation and bone resorption. Many risk factors have been identified for 
osteoporosis including genetic factors,  race, sex, age, menopausal state, 
smoking, medications, alcohol intake, exercise and nutrition (Srivastava & 
Deal, 2002,  Odabasi, et al., 2008, Pepa and Brandi, 2016).  Osteoporosis 
affects millions people worldwide, predominantly postmenopausal women. 
(Castiglional et al., 2013). It is estimated that over 200 million people 
worldwide have osteoporosis. Although osteoporosis is more common in 
women than in men, the incidence in men is increasing. The prevalence of 
osteoporosis is continuing to escalate with the increasingly elderly population.   
(Reginster& Burlet, 2006). The increase of life expectancy and so the old age 
in the society in developing countries such as the Middle East has led to an 
increase in the prevalence of osteoporosis (Memon, 1998).  Dietary intake is 
an important modifiable factor for bone health. The process of bone formation 
requires an adequate and constant supply of nutrients, such as calcium, protein, 
magnesium, phosphorus, vitamin D, potassium, and fluoride. However, there 
are several other vitamins and minerals needed for metabolic processes related 
to bone, including manganese, copper, boron, iron, zinc, vitamins A, K, C, and 
B complex (Srivastava et al., 2002). Trace elements such as iron, magnesium, 
manganese, zinc, copper, and iodine, that occur in very small amounts in 
organisms and are essential for many physiological and biochemical processes 
are affected in osteoporosis individuals. Magnesium (Mg) appears to be 
important in bone cell activity. It is shown to be mitogenic for osteoblasts and 
its depletion causes cellular growth inhibition, in vitro (Odabasi, et al., 2008).   
Razmandeh et al. (2014) compared trace elements (Zinc, Copper and 
Magnesium) concentration in nail, urine and serum among osteoporotic 
postmenopausal women with control group in Iran. The urine level of trace 
elements had significant difference between osteoporotic groups and controls 
(p < 0.001). Moreover, Mg level significantly differed in serum between the 
two groups (p < 0.04). There was no statistically significant difference in trace 
minerals in nail beyond groups. Mahdavi Roshan et al., 2015 founded that 
serum levels of zinc and copper were significantly (p<0.05) lower than normal 
range and 40% of participants had serum magnesium level lower than normal 
range; they recommended magnesium, zinc, calcium and cupper 
supplementation (Mahdavi-Roshan et al., 2015).  
Serum concentrations of magnesium, zinc and copper were measured 
in postmenopausal women with osteoporosis (n = 40), osteopenia; an early 
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stage of osteoporosis (n = 40) or normal bone mineral density (n = 40). Mean 
concentrations of magnesium and zinc were significantly lower in 
osteoporotic women than in both osteopenic women and normal women. 
There were no significant differences observed between the osteopenic, 
osteoporotic and control groups with respect to copper levels (Mutlu et al., 
2007). Odabasi and others measured magnesium (Mg), zinc, copper, 
manganese, and selenium by atomic absorptions spectrophotometry in both 
postmenopausal women with osteoporosis and healthy postmenopausal 
women. Only statistically significant difference between the osteoporotic 
(51.51 [15.40]μg/mL) and healthy subjects (54.54 [15.42] μg/mL) was 
observed in red blood cell (RBC) magnesium concentration (Z = -2.07, P = 
0.039) (Odabasi et al., 2008).  
Sahmani compare the serum levels of zinc (Zn), copper (Cu) and lipid 
profile between the postmenopausal women suffering from osteoporosis and 
the healthy controls. The serum levels of Zn and Cu were similar in both 
groups (P>0.05). Serum levels of low-density lipoprotein (LDL) and total 
cholesterol (TC) in osteoporosis group was significantly higher when 
compared to the controls (P<0.05). Correlation analysis showed that there was 
significant association between body mass index (BMI) and BMD values (P < 
0.05). There was no correlation between serums Zn, Cu levels with lipid 
profile (P > 0.05). However, they found a negative significant correlation 
between BMD with LDL (r =-0.31, P=0.001) and total cholesterol levels (r=-
0.26, P = 0.006) (Sahmani et al., 2014).  
Stendig-Lindbergl et al. (1993) investigated the effect of magnesium 
treatment on trabecular bone density in postmenopausal osteoporosis. No new 
fractures occurred. Twenty-two patients (71%) responded by a 1-8% rise of 
bone density. The mean bone density of all treated patients increased 
significantly after 1 year (P< 0.02) and remained unchanged after 2 years (P > 
0.05). The mean bone density of the responders increased significantly both 
after one year (P < 0.001)and after 2 years (P< 0.02), while in untreated 
controls the mean bone density decreased significantly (P< 0.001). 
Magnesium therapy, which had no ill effects, prevented fractures and resulted 
in significant increase of bone density in 71% and arrest of bone loss in another 
16% of the patients holds great promise in postmenopausal osteoporosis 
treatment. Pan et al. (2017) determined the role of IDA as a risk factor for 
osteoporosis by analyzing a large nationwide population-based sample. In a 
sample of 1,000,000 randomly sampled individuals from the 1998–2012. 
Taiwan National Health Insurance Research Database, patients with IDA (case 
group (n = 35,751)) and individuals without IDA (control group (n = 178,755)) 
were compared. Compared with individuals without IDA, the risk for 
osteoporosis was even higher for patients with IDA who received intravenous 
ferrum therapy (adjusted HR = 2.21; 95% CI = 1.85–2.63). In contrast, the risk 
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for osteoporosis was reduced for patients with IDA who received a blood 
transfusion (adjusted HR = 1.47; 95% CI = 1.20–1.80). As a predictor, prior 
IDA is a significant and independent risk factor for development of 
osteoporosis. 
The Palestinian Osteoporosis Prevention Society conducted a study on 
the prevalence of osteoporosis among postmenopausal women, they found that 
around 40% of postmenopausal women were affected (Abd-Alhameed et al., 
2010). Trace studies are carried out on osteoporotic patients in Gaza Strip 
regarding trace minerals levels. Assessment of copper, iron, phosphorus, 
magnesium and calcium levels in osteoporotic patients; has not been 
performed in Gaza Strip; hence this study aimed to evaluate levels of these 
trace minerals in those patients.  However, this work aimed to study the 
relationship between levels of copper, iron, phosphorus, magnesium and 
calcium and occurrence of osteoporosis in southern Gaza patients, in relation 
to dietary habits and life style. 
Objectives: To study the relationship between copper, iron, 
phosphorus, magnesium and calcium levels and occurrence of osteoporosis in 
southern Gaza patients. Also to investigate the correlation between trace 
minerals levels and dietary habits and life style in osteoporotic patients.  
          Materials and Methods Study design and subjects: The present study 
is a case–control study. The study populations are osteoporotic patients aged 
40-70 years attending osteoporotic clinics at European Gaza Hospital 
Southern Gaza Strip. Controls will be apparently healthy non osteoporotic 
individuals. Non probability accidental sample of 35 osteoporotic patients, at 
European Gaza Hospital, Southern Gaza Strip. 35 apparently healthy non-
osteoporotic controls will be selected from the general population. Cases and 
controls will be age and gender matched. Osteoporotic patients aged <40 and 
>70 years and chronic conditions like heart disease, renal failure, malignancy 
are excluded from the study. 
Blood sampling: For each participant, 5 ml of blood was collected by 
venipuncture in a plain vacutainer for serum preparation to determine 
hormonal profile and HbA1c. The collected blood samples were allowed to 
clot at room temperature, and serum was separated by centrifugation at 3000 
RPM for 10 min and stored at −20°C until analysis. 
Data collection and biochemical analysis: Subjects data is collected 
through Questionnaire interview. Ethical consideration A request letter to 
execute the study was sent to Palestinian Ministry of Health administration 
from Al-Aqsa-University. The study was carried out according to principles 
of Helsinki Declaration. Participation was voluntary, and participants were 
given a full explanation about the goals of the study. Confidentiality of all 
participants was maintained. 
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Statistical analysis Data analyses were performed using the Statistical 
Package for the Social Sciences (SPSS) software (version 17). Continuous 
data were expressed as mean ± standard deviation whereas categorical data as 
number (%). Comparison of variables between cases and controls was 
performed with an unpaired t-test for continuous data and Chi-square for 
categorical data. Pearson correlation coefficients were calculated for trace 
minerals and lifestyle. P < 0.05 was considered statistically significant. 
Methods: The commercial kits for trace minerals measurement were 
purchased from DiaSys Diagnostic Systems, Holzhein, Germany. 
Determination of Calcium Principle: Calcium with arsenazo III at 
neutral pH yields a blue colored complex, whose intensity is proportional to 
the calcium concentration. Interference by magnesium is eliminated by 
addition of 8-hydroxyquinoline-5-sulfonic acid (Endres, et al., 1999, 
Michaylova, et al., 1971). 
Determination of Phosphorus Principle: Inorganic phosphorus 
reacts ammonium molybdate in an acidic medium to form a 
phosphomolybdate complex. Maximum complex absorption is at 340 nm. 
(Endres, et al., 1999, Burtis, et al., 1999) 
Determination of  Iron Principle: Iron bound to transferrin is 
released in an acidic medium as ferric iron and is then reduced to ferrous iron 
in the presence of ascorbic acid. Ferrous iron forms a blue complex with 
Ferene. The absorbance at 595 nm is directly proportional to the iron conc. 
(Guder, et al., 2001, Young, 2000)   
Determination of Copper Principle: Colorimetric test without 
deproteinization of the sample. At pH 4.70, in a buffered media, copper is 
released from ceruloplasmine complex and form the specific comlexant3-5 
DiBr-PAESA a stable colored complex. The color intensity is proportional to 
the amount of copper in the sample. (Brutis, et al., 1999, Kaplan, et al., 1984) 
Determination of Magnesium Principle: Magnesium in alkaline solution reacts 
with the chromogenxylidyl Blue to form a purple complex. The presence of 
glycoletherdiaminotetr acetic acid (GEDTA) that binds calcium ions in the 
reagent allows the reaction to be specific. Purple color intensity at 520 nm is 
proportional to the concentration of magnesium in the sample (Thomas, 1998, 
Chitto et al., 1994, Khvedelidze et al., 2019 ). 
Results: The present study included 70 individuals divided into two groups, 
35 patients Of osteoporosis aged from30-75 years and the second group 35 
healthy subjects aged from 30-75 years to act as a control group. Table 1 
showed similar physical and socioeconomic characteristics of the study 
population 
  
European Scientific Journal July 2020 edition Vol.16, No.21 ISSN: 1857-7881 (Print) e - ISSN 1857-7431 
 
201 
Table 1: Physical and Socioeconomic characteristics of the study population 
General characteristics 
Cases 
(n=35) 
Controls 
(n=35) 
Statistical test P-value 
Age (years) 
Mean±SD 
(Min-max) 
 
 
61.1±9.6 
(30-73) 
56.3±9 
(41-75) 
t = 2.143 0.036 
Weight (cm) 80.5±10.7 
(51-104) 
88.3±20.8 
(56-170) 
t = -1.959 0.054 
Height (cm) 160.6±11.2 
(130-187) 
165.3±8.5 
(150-188) 
t = -1.982 0.051 
BMI (Kg/M2) 31.6±5.9 
(19.9-53.3) 
32.5±8.0 
(18.3-58.8) 
t = -0.551 0.583 
 
n (%) 
    
Employment 6(17.1) 1(2.9) 3.96 0.046 
Yes 29(82.9) 34(97.1)   
No     
Sex     
Male 6 (17.1) 6 (17.1) 2 = 0.000 1.000 
Females 29 (82.9) 29 (82.9)   
Age (years)     
<55 9 (25.7) 17 (48.6) 2 = 5.080 0.079 
55-65 13 (37.1) 12 (34.3)   
>65 13 (37.1) 6 (17.1)   
     
Family history 23(65.7) 17(48.6) 2.10 0.147 
No 12(34.30 18(51.4)   
Yes     
Marital status     
Married 33 (94.3) 33 (94.3) 2 = 0.000 1.000 
Single 2 (5.7) 2 (5.7)   
     
     
     
Exposure to 
sun     
No 1 (2.9) 3 (8.6) 2 = 4.251 0.373 
Few 3 (8.6) 2 (5.7)   
Often 10 (28.6) 10 (28.6)   
Usually 5 (14.3) 10 (28.6)   
Always 16 (45.7) 10 (28.6)   
     
*P-value significant at p≤0.05; n: number of the subjects; NIS: new Israeli shekel &  
2 : chi-square test. BMI: Body mass index; t: student t-test 
 
Table 2 showed the distribution of the dietary habits and life style 
among the study population, there were no significant differences between the 
two groups; but in the daily exercise there was a significant difference 
(p=0.003); were 80%of control do the daily exercise but only 45.7 %of cases 
do this activity.  In addition, there was a significant difference (p=0.002); 
between the two groups in the number of fractures were 60%of cases suffer 
from fractures but only 22.9%of control suffer from this condition. 
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         Table 3 showed the trace minerals level among the study population; 
there was a significant differences between the two groups; in copper (cases 
74.3±9. μg/dL 8, control 98.3±15.2 μg/dL) and magnesium (cases 
1.56±0.18mg/dL but control 2.06±0.13 mg/dL). Levels judged by p value of 
<0.001 but there was no significant differences in the levels of iron, calcium 
and phosphorus. 
Table 2: Dietary habits and life style among the study population 
General characteristics 
Cases 
(n=35) 
n (%) 
Controls 
(n=35) 
n (%) 
Statistical test 
2 P-value 
Involved in accident and 
fractures     
Yes 21 (60.0) 8 (22.9) 9.950 0.002 
No 14 (40.0) 27 (77.1)   
Deal with soft drinks     
Yes 19 (54.3) 23 (65.7) 0.952 0.329 
No 16 (45.7) 12 (34.3)   
Coffee and Tea drink in 
abundance     
Yes 32 (91.4) 33 (94.3) 0.215 0.643 
No 3 (8.6) 2 (5.7)   
Practice exercises (daily)     
Yes 16 (45.7) 28 (80.0) 8.811 0.003 
No 19 (54.3) 7 (20.0)   
Chronic disease     
No 16 (45.7) 14 (40.0) 0.233 0.629 
Yes 19 (54.3) 21 (60.0)   
If yes (Chronic disease)     
Cancer 1 (5.3) 0 (0.0) 2.239 0.524 
DM 1 (5.3) 2 (9.5)   
HT 16 (84.1) 16 (76.2)   
DM & HT 1 (5.3) 3 (14.3)   
Deal with any drug or 
hormonal treatment     
No 14 (40.0) 13 (37.1) 0.060 0.806 
Yes 21 (60.0) 22 (62.9)   
If yes (Hormonal treatment)     
DM 12 (57.1) 3 (13.6) 9.844 0.007 
HT 9 (42.9) 17 (77.3)   
DM & HT 0 (0.0) 2 (9.1)   
Smoking     
Yes 2 (5.7) 3 (8.6) 0.215 0.643 
No 33 (94.3) 32 (91.4)   
Meat and fish intake     
Yes 33 (94.3) 34 (97.1) 0.348 0.555 
No 2 (5.7) 1 (2.9)   
Milk and its derivatives     
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Yes 26 (74.3) 30 (85.7) 1.429 0.232 
No 9 (25.7) 5 (14.3)   
Number of eggs in week     
Yes 32 (91.4) 30 (85.7) 0.565 0.452 
No 3 (8.6) 5 (14.3)   
Fruits and vegetables in 
take     
Yes 34 (97.1) 34 (97.1) 0.000 1.000 
No 1 (2.9) 1 (2.9)   
Number of meals (daily)     
One 3 (8.6) 0 (0.0) 3.082 0.214 
Two 21 (60.0) 23 (69.7)   
Third 11 (31.4) 10 (30.3)   
*P-value significant at p≤0.05; n: number of the subjects;  
DM: Diabetes mellitus; HT: Hypertension & 2 : chi-square test. 
 
Table 3: Trace minerals among the study population 
Parameters 
Cases 
(n=35) 
Mean±SD 
Controls 
(n=35) 
Mean±SD 
Statistical test 
% 
difference 
t P-value 
Cu (μg/dL) 
(Min - max) 
74.3±9.8 
(60-96.5) 
98.3±15.2 
(58.6-
132.4) 
-27.8 -7.823 < 
0.001 
Mg (mg/dL) 
(Min - max) 
1.56±0.18 
(1.4-2.47) 
2.06±0.13 
(1.68-2.48) 
-27.8 -13.081 < 
0.001 
Fe (µg/dL) 
(Min - max) 
55.8±24.1 
(26-141) 
50.8±21.9 
(21.4-109) 
4.7 0.904 0.369 
Ca (mg/dL) 
(Min - max) 
8.8±0.4 
(8-9.7) 
8.9±0.4 
(8-9.7) 
-0.5 -0.862 0.392 
Ph (mg/dL) 
(Min - max) 
3.4±0.5 
(2.6-4.8) 
3.3±0.6 
(2.4-4.8) 
1.5 0.751 0.455 
*P-value significant at p≤0.05; n: number of the subjects; SD: standard deviation,  
t: student t-test; Cu: Copper; Ph: phosphorus; Fe: iron; Mg: Magnesium & Ca: Calcium 
 
Table 4 separated the cases and control according to the normality of trace 
minerals levels. This table indicated a significant differences in the cases and 
control in the levels of copper and magnesium. In cases, 40% suffer from low 
level of copper but only 2.9% of control suffer from low copper level. Also 
74.3%of cases suffer from low magnesium level but no one suffer from low 
magnesium level on the control. There was no significant differences in the 
levels of iron, calcium and phosphorus in control and cases.  
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Table 4: Trace minerals among the study population 
Parameters 
Cases 
(n=35) 
n (%) 
Controls 
(n=35) 
n (%) 
Statistical test 
2 P-value 
Cu (μg/dL)     
Low 14 (40.0) 1 (2.9) 14.339 <0.001 
Normal 21 (60.0) 34 (97.1)   
Mg (mg/dL)     
Low 26 (74.3) 0 (0.0) 41.364 <0.001 
Normal 9 (25.7) 35 (100.0)   
Fe (µg/dL)     
Low 8 (22.9) 11 (31.4) 0.650 0.420 
Normal 27 (77.1) 24 (68.6)   
Ca (mg/dL)     
Low 9 (25.7) 7 (20.0) 0.324 0.569 
Normal 26 (74.3) 28 (80.0)   
Ph (mg/dL)     
Low 1 (2.9) 5 (14.3) 2.917 0.088 
Normal 34 (97.1) 30 (85.7)   
*P-value significant at p≤0.05; n: number of the subjects; 2 : chi-square test; Cu: Copper; 
Ph: phosphorus; Fe: iron; Mg: Magnesium & Ca: Calcium 
 
Table 5 shows  the results of the  correlation between trace minerals, dietary 
habits and life style in the studied parameters, it shows a negative 
correlation between calcium and Phosphorus (r=-0.735, Figure1), positive 
correlation between copper and magnesium levels (r=0.627, Figure 2), a 
positive correlation between number of meals and copper level (r=0.263, 
Figure 3), also a positive correlation between calcium level and the daily 
exercise (r=0.449, Figure 4). 
Table 5: Correlation between trace minerals, dietary habits and life style in the studied parameters 
Parameters 
Ph 
(mg/dL) 
Cu 
(μg/dL) 
Fe 
(µg/dL) 
Ca 
(mg/dL) 
Mg 
(mg/dL) 
r P-value r 
P-
value 
r 
P-
value 
r 
P-
value 
r 
P-
value 
Ph (mg/dL) - - 0.022 0.855 0.098 0.418 -0.735 0.000 0.002 0.985 
Cu (μg/dL) 0.022 0.855 - - -0.147 0.224 -0.055 0.649 0.627 0.000 
Fe (µg/dL) 0.098 0.418 -0.147 0.224 - - 0.014 0.911 -0.094 0.441 
Ca (mg/dL) -0.735 0.000 -0.055 0.649 0.014 0.911 - - -0.032 0.795 
Mg (mg/dL) 0.002 0.985 0.627 0.000 -0.094 0.441 -0.032 0.795 - - 
Age (years) 0.140 0.248 -0.110 0.364 -0.046 0.703 -0.230 0.056 -0.124 0.307 
Weight (cm) 0.081 0.505 0.171 0.158 -0.112 0.356 -0.092 0.447 0.209 0.082 
Height (cm) 0.085 0.486 0.106 0.382 0.040 0.742 -0.015 0.902 0.188 0.119 
BMI (Kg/md2) 0.029 0.812 0.082 0.501 -0.130 0.284 -0.090 0.458 0.069 0.573 
Number of 
meals (daily) 
0.157 0.201 0.263 0.030 -0.121 0.324 -0.125 0.308 0.113 0.358 
Frequency 
Coffee and Tea 
drink in 
-0.125 0.328 0.091 0.479 0.170 0.183 0.190 0.137 -0.108 0.398 
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abundance 
(daily) 
Frequency 
practice daily 
exercises 
(weekly) 
-0.203 0.266 0.199 0.275 -0.171 0.349 0.449 0.010 0.304 0.091 
Frequency 
intake  meat 
and fish 
(weekly) 
0.009 0.941 0.049 0.693 -0.021 0.868 0.069 0.575 -0.098 0.426 
Frequency 
intake milk and 
its derivatives 
(weekly) 
-0.048 0.723 0.115 0.393 -0.021 0.877 0.031 0.819 0.107 0.428 
Frequency 
intake eggs 
(weekly) 
-0.012 0.923 0.149 0.249 -0.103 0.427 0.007 0.956 0.004 0.973 
Frequency 
intake fruits 
and vegetables 
(weekly) 
0.003 0.980 0.181 0.145 -0.092 0.461 -0.005 0.969 0.033 0.795 
*P-value significant at p≤0.05; n: number of the subjects; BMI: Body mass index; Cu: Copper; Ph: 
phosphorus; Fe: iron; Mg: Magnesium; Ca: Calcium & r: Pearson correlation 
 
Figure (1): The negative correlation between Ph and Ca. 
 
Figure (2): The positive correlation between Mg and Cu. 
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Figure (3): The positive correlation between number of meals and Cu. 
 
 
Figure (4): The positive correlation between frequency practice exercises and Ca. 
 
Discussion 
The involvement of trace minerals in bone metabolism and 
osteoporosis have not yet been clarified. Numerous investigators recorded 
significant changes in trace minerals levels in osteoporotic patients. Calcium, 
magnesium and copper are essential for normal development of skeleton (Jan 
Aaseth et al., 2012).  Iron is a component of hemoglobin; oxygen transport 
protein, phosphorus and calcium are essential components of bone, 
phosphorus is needed for energy production in all cells. Lack of calcium in the 
diet leads to a form of leaching out of bone mineral content (osteoporosis). 
Copper is an antioxidant, involved in protein metabolism, coenzymes for 
many enzymes, involved in healing processes. Magnesium is important in 
calcium and potassium hemostasis. Numerous biochemical and physiological 
processes require magnesium, including energy production,, protein 
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syntheses, muscle contraction and vascular tone. Zinc and copper are essential 
cofactors for enzymes involved in the synthesis of various bone matrix 
constituents (Nicola M Lowe et al ., 2009). The causes of age related changes 
in bone mass are multifactorial and include genetic predisposition, nutritional 
factors endocrine changes habitual exercise levels and body weight. In the 
present study separation of cases and control according to their physical and 
socioeconomic characteristics does not show any significant differences 
between cases and control except in the percentage of employment patients 
(17.1%) comparing with control (2.9%), (p=0.047). Also separation of cases 
and control according to dietary habits does not show any differences but life 
style shows a significant differences (p=0.003) in the daily exercise, 
percentage of individuals exercise daily in cases 45.7% but in control 80% of 
individuals exercise daily ; the same result was gained by Chaconas, and Russ, 
, 2013). Table 4 shows a significant differences (p<0.001) in copper and 
magnesium levels in cases and control (Figures 1 and 2), but levels of calcium, 
phosphorus and iron does not show any differences. Separation of cases and 
control according to the normality of trace minerals levels explain that 40%of 
cases have low copper level but 2.9%of control have low level this difference 
is statistically significant p=<0.001. 74.3%of cases have low magnesium level 
but 0%of control have low level, p=<0.001. For calcium, phosphorus and iron 
levels there are no differences between the studied groups. 
Results of the present work is in agreement with the previous studies, 
Castiglioni and others; reported that level of magnesium is less than normal in 
women with postmenopausal osteoporosis (Castiglional et al., 2013, El habiby 
et al., 2017 ).  
The present study recorded a significant negative correlation (r=-
0.735, p=0.000, Figure 1) between calcium and phosphorus levels and a 
significant positive correlation (r=0.627, p=0.00, Figure 2) between 
magnesium and copper levels. In addition, the present work indicated a 
significant correlation between copper level and number of daily meals 
(r=0.263, p=0.030, Figure 3), and a positive correlation between calcium level 
and daily exercise (r=0.449, p= 0.01, Figure 4). Copper is a cofactor for lysyl 
oxidase that required in cross-linking of collagen and elastin. Cu deficiency 
causes inhibition of bone growth and osteoporosis (Yee CD et al., 1995). In a 
more recent study, they recorded that magnesium deficiency is contributed to 
osteoporosis directly by acting on crystal formation and on bone cells and 
indirectly by affecting the secretion and activity of parathyroid hormone and 
by promoting low grade inflammation. Consequently, optimizing magnesium 
intake might represent an effective and low cost preventive measure against 
osteoporosis in individuals with documented magnesium deficiency 
(Castiglional et al., 2013).               
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Gur A et al., 2002 indicated that serum values of Mg, copper and Zn 
(p<0.05) were significantly lower in osteoporotic patients group than those in 
the control group. They suggested that calcitonin therapy regulates Mg, Cu, 
and Zn levels in postmenopausal osteoporosis, and when serum calcium and 
phosphorus were normal, Mg, Cu, and Zn were more useful for evaluation.  
Magnesium (Mg) appears to be important in bone cell activity and calcium 
metabolism. It is shown to be mitogenic for osteoblasts and its depletion 
causes cellular growth inhibition, in vitro (Razmandeh et al. 2014). Previous 
studies showed that Mg levels in 24-hours urinary excretion were increased in 
postmenopausal women compared with premenopausal women (Srivastava et 
al., 2002). Lee et al., (2014) evaluated the relationships between dietary 
calcium, phosphorus, calcium/phosphorus intake ratio, and bone mass in 
Korean adults. There were positive relationships between dietary calcium 
intake, calcium/phosphorus intake ratio and femoral neck BMD in men older 
than 50 years, and dietary calcium intake showed positive associations with 
BMD for whole body in premenopausal women. Madhavi-Roshan et al., 
(2015) showed that the mean dietary intake of magnesium, zinc and calcium 
in post-menopausal women with low bone density were significantly lower 
than recommended dietary allowance. The mean serum levels of zinc (P = 
0.001) and copper (P = 0.000) were significantly lower than normal range and 
40.4% of this participants had serum magnesium levels lower than normal 
range. Mg, Zn and Cu are necessary for the transmission of nerve impulses, 
temperature regulation, detoxification, energy production, and the formation 
of healthy bones and teeth.  Sierpinskaj et al., (2014) recorded that enamel in 
adult individuals with severe tooth wear is low in copper content.  The causes 
of osteopenia and osteoporosis are multifactorial, involving genetics, 
endocrine function, exercise, life style, disease status, metabolic factors, age, 
BMI, rheumatoid arthritis, smoking status, alcohol status and nutritional 
considerations. Results of the present study is comparable to the results of our 
previous study carried out on patients from northern Gaza we recorded a 
relationship between osteoporosis and many risk factors such as daily 
inactivity, ages, hormonal therapy and coffee drink (Elhabiby et al., 2017). 
Element deficiency may occur for several reasons; deficiencies are primarily 
due to renal wasting and are exacerbated by dietary element deprivation, 
gastrointestinal losses with diarrhea or vomiting, as well as concomitant use 
of drugs such as diuretics and aminoglycosides. Element deficiency may 
contribute to increased bone loss due to its effects on mineral homeostasis, 
trace element supplementation up to the recommended daily allowance, 
especially with Mg, Zn and Cu, may have beneficial effects on bone density. 
High Zn and Mg foods may be beneficial in post-menopausal women 
(Stendig-Lindbergl et al,. 1993, Srivastava et al., 2002, Madhavi-Roshan et 
al., 2015, Elhabiby et al., 2017).  
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The recommended daily intake of magnesium necessary for bone 
health in young people under 30 years of age is 400 mg, in older subjects it is 
320 mg and 420 mg for females and males, respectively. 
Castiglioni  et al., 2013  suggested that several direct and indirect 
mechanisms contribute to the effects of low magnesium on bone density: low 
magnesium can directly affect the bone by altering the structure of apatite 
crystals; magnesium deficiency is also associated with reduction of PTH and 
1,25 (OH2) D levels and low grade inflammation and endothelial dysfunction, 
with a well-known relation between inflammation and bone loss.  
An extensive analysis by Hayhoe et al. (2015) in a large group of adult 
subjects of both genders showed that dietary magnesium and serum 
magnesium were positively associated with calcaneal bone ultrasound analysis 
in women and negatively associated with fracture risk in both women and men. 
Furthermore, magnesium supported facilitated postoperative healing in 
orthopedic patients, in whom degradable fixation magnesium devices were 
used (Chaya et al. 2015). 
Deficiency or excess of Zn Cu, Mn, Mg, Fe Boron and cobalt  
influence bone mass and bone quality in adulthood as well as in childhood and 
adolescence. However, some protective elements may become toxic under 
certain conditions (Zofkova et al., 2017). 
Xinhua et al., 2018 found that low concentration of serum copper lead 
to lower BMD whereas higher serum levels are associated with an increased 
risk of fracture, especially in men. Activity of lysyl oxidase for covalent cross-
linking of collagen is copper ions dependent. Collagen is the mail component 
of bone tissue extracellular matrix (Ettinger, 2017). Recently they used copper 
containing mesoporous bioactive glass nano particles as multifunctional agent 
for bone regeneration (Bari et al., 2017). Elderly patients with fractures of the 
femoral neck were found to have significantly lower serum copper levels than 
age and sex matched controls (Conlan et al., 1990). Post-menopausal women 
with a high dietary calcium intake combined with a high serum copper level 
had a greater lumbar bone density than women with low calcium intake and 
low serum copper (Haward et al, 1990, Allagoa, 2018). Dietary copper is 
available in a wide variety of foods including meats, seafood, nuts and grains. 
The recommended daily intake of copper adequate for bone health in adults is 
0.9 mg/day (Charles et al., 2012). 
Copper plays an important role in regulation of bone growth and 
development of the skeleton. The element induces the formation of lysine 
crosslinks in collagen and elastin via lysyl oxidase activation. As a cofactor of 
antioxidant enzymes, it removes bone free radicals that cause the osteoclast 
activation (Kubiak et al. 2010). In addition, copper inhibits osteoclastic bone 
resorption directly (Li and Yu 2007). Altogether, copper increases bone 
strength and helps to maintain the optimal state of bone quality. The 
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recommended daily intake of copper for adequate bone quality in adults is 0.9 
mg/day (Price et al., 2012, Lrhorfi, 2016). Epidemiological studies and clinical 
trials showed micronutrients could potentially have a positive impact on bone 
health, preventing bone loss and fractures, decreasing bone resorption and 
increasing bone formation. Consequently, optimizing micronutrients intake 
might represent an effective and low-cost preventive measure against 
osteoporosis (Pepa et al., 2016, Ibrahim et al., 2017).  
 
Conclusion  
Copper and magnesium levels are significantly lower in 
postmenopausal women and men with osteoporosis. Optimizing levels of 
those trace minerals in old people is beneficial in prevention of osteoporosis. 
Daily exercises and ingestion of food containing trace minerals is 
recommended for all ages.  
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